View Older Stories View More Recent Stories

Nov 10, 2021 05:06PM Lumos Pharma to Participate in Upcoming Investor Conferences
Nov 10, 2021 08:00AM Endologix Names Dr. Matthew Thompson President and CEO
Nov 8, 2021 08:01AM Biotech Acquisition (BIOT) and Blade Therapeutics Announce Definitive Merger Agreement
Nov 8, 2021 08:00AM Biotech Acquisition Company and Blade Therapeutics Announce Definitive Merger Agreement
Nov 3, 2021 04:01PM Lumos Pharma Reports Third Quarter 2021 Financial Results and Provides Clinical Updates
Nov 3, 2021 04:01PM Lumos Pharma Reports Third Quarter 2021 Financial Results and Provides Clinical Updates
Nov 3, 2021 10:17AM Second Annual $500,000 XSeed Award Launched by Deerfield Management to Support Underfunded and Underrepresented NYC Life Science Startups
Oct 22, 2021 04:06PM DFP Healthcare Acquisitions (DFPH) Schedules Special Meeting to Approve Proposed Merger with The Oncology Institute for November 12th
Oct 22, 2021 04:05PM DFP Healthcare Acquisitions Corp. Announces Special Meeting Date to Approve Proposed Business Combination with The Oncology Institute
Oct 21, 2021 09:37PM Form 3 Xilio Therapeutics, Inc. For: Oct 21 Filed by: DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)
Oct 21, 2021 04:05PM Lumos Pharma to Report Third Quarter 2021 Financial Results and Host Conference Call on November 3, 2021
Oct 21, 2021 04:05PM Lumos Pharma to Report Third Quarter 2021 Financial Results and Host Conference Call on November 3, 2021
Oct 13, 2021 09:00AM Lark Health Raises $100 Million Series D Funding Round Led by Deerfield Management
Oct 11, 2021 12:00PM DeepSight™ Technology Announces $25M Series A Funding Round
Oct 6, 2021 04:56PM Caring Cross Presents at the 2021 BioFuture Conference
Oct 5, 2021 08:01AM Salarius Pharmaceuticals to Present at the 2021 BioFuture Conference
Sep 29, 2021 08:04AM BioAtla (BCAB) Announces Private Placement of 2.7 Million Shares
Sep 29, 2021 08:03AM BioAtla Announces Private Placement of 2.7 Million Shares
Sep 29, 2021 08:00AM Endologix Initiates Randomized Study of ALTO® Abdominal Stent Graft System
Sep 29, 2021 06:32AM Amicus Therapeutics (FOLD) and ARYA Sciences Acquisition Corp IV (ARYD) Announce Formation of a Next-Generation Genetic Medicine Company: “Caritas Therapeutics”
Sep 29, 2021 06:30AM Amicus Therapeutics and ARYA Sciences Acquisition Corp IV Announce Formation of a Next-Generation Genetic Medicine Company: “Caritas Therapeutics”
Sep 28, 2021 10:58AM The New York Academy of Medicine to Honor Innovators in Health with Remarks from Dr. Anthony Fauci
Sep 23, 2021 08:00AM Behavioral Health Leader Christina Mainelli Joins Quartet Health to Accelerate Strategic Growth
Sep 16, 2021 07:31AM Vincerx Pharma, Inc (VINC) Announces 3.5M Share Private Placement at $14.50
Sep 16, 2021 07:30AM Vincerx Pharma Announces $50 Million Private Placement
Sep 9, 2021 08:00AM Dr. Patrice Harris Joins Quartet Health's Board of Directors
Sep 9, 2021 07:00AM iECURE Launches With $50 Million Series A Financing to Develop In Vivo Gene Insertion Approaches for Devastating Diseases
Sep 8, 2021 08:00AM HilleVax Closes $135 Million Crossover Financing to Advance Clinical Stage Norovirus Vaccine Candidate
Sep 7, 2021 08:00AM Demy-Colton Announces BioFuture™ Speaker Lineup and Panel Sessions on October 5-6 at Cure by Deerfield in New York City
Sep 2, 2021 08:17PM Form 4 Acutus Medical, Inc. For: Jun 17 Filed by: DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)
Sep 2, 2021 01:05PM Civetta Therapeutics Announces the Appointment of Christopher D. Roberts, Ph.D., as CEO
Sep 2, 2021 08:00AM Lumos Pharma to Participate in September Investor Conferences
Sep 2, 2021 08:00AM Lumos Pharma to Participate in September Investor Conferences
Aug 31, 2021 08:00AM ARS Pharmaceuticals Raises $55 Million in Series D Funding for Launch Preparations of Neffy™ (epinephrine nasal spray)
Aug 25, 2021 09:45AM The Cure Commences Fall Session of the Cure Symposia as Part of Its In-House Educational Programming
Aug 25, 2021 07:00AM Blade Therapeutics Announces FDA Activation of IND Application to Investigate Cudetaxestat, a Non-Competitive Autotaxin Inhibitor, in Idiopathic Pulmonary Fibrosis (IPF)
Aug 16, 2021 04:32PM Form 13F-HR DEERFIELD MANAGEMENT For: Jun 30
Aug 10, 2021 06:01AM Form SC 13D DA32 Life Science Tech Filed by: DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)
Aug 9, 2021 09:11PM Form 4 DA32 Life Science Tech For: Aug 05 Filed by: DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)
Aug 9, 2021 07:30AM Miravo Healthcare™ Announces Second Quarter 2021 Results
Aug 5, 2021 08:00AM Lumos Pharma Reports Second Quarter 2021 Financial Results and Provides Clinical and Corporate Updates
Aug 5, 2021 08:00AM Lumos Pharma Reports Second Quarter 2021 Financial Results and Provides Clinical and Corporate Updates
Aug 5, 2021 07:00AM PepGen Announces Closing of $112.5 Million Crossover Financing to Advance Transformative Therapies for Neuromuscular Diseases
Aug 4, 2021 09:00AM Deerfield Announces New $1.4-billion Private Investment Fund
Aug 3, 2021 08:27PM Form 4 DA32 Life Science Tech For: Jul 30 Filed by: DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)
Aug 3, 2021 08:12AM Lumos Pharma, Inc. (LUMO) Announces Industry Veteran, David B. Karpf, MD, has Joined the Company as Chief Medical Officer
Aug 3, 2021 08:00AM Lumos Pharma Announces Industry Veteran, David B. Karpf, MD, has Joined the Company as Chief Medical Officer
Aug 3, 2021 08:00AM Lumos Pharma Announces Industry Veteran, David B. Karpf, MD, has Joined the Company as Chief Medical Officer
Aug 2, 2021 08:04AM Lumos Pharma, Inc. (LUMO) Announces the Promotion of COO and Chief Scientific Officer, John McKew, PhD, to President
Aug 2, 2021 08:00AM Lumos Pharma Announces the Promotion of COO and Chief Scientific Officer, John McKew, PhD, to President
View More Recent Stories View Older Stories